Manufacturing News of Note: Catalent expands; Hospira and Novartis issue recalls


> Catalent is investing $9 million in a clinical supply facility in San Diego, California. Release

> Nichi-Iko Pharmaceutical, parent of Sagent Pharmaceuticals, says its Canadian subsidiary, Omega Laboratories, has won FDA approval for its site in Montreal to manufacture products for the U.S. Release

> Pfizer's Hospira is voluntarily recalling one lot of bacteriostatic water used to dilute drugs because vials may not be sterile and bring a risk of bacterial infections. Release

> Novartis is recalling one lot of asthma med Xolair in Canada because the vials may include silicone oil. Release

Suggested Articles

CureVac and Tesla are teaming up to produce the German vaccine maker's molecular RNA printers, Tesla CEO Elon Musk tweeted Thursday.

The FDA knocked a California compounding pharmacy facility for a suite of sanitary concerns, including the presence of ants in the plant.

Merck Animal Health will plow $100 million into its DeSoto, Kansas, plant to scale up production of animal vaccines.